Accessibility Menu
 
vTv Therapeutics logo

vTv Therapeutics

(NASDAQ) VTVT

Current Price$40.92
Market Cap$162.15M
Since IPO (2015)-91%
5 Year-64%
1 Year+135%
1 Month+19%

vTv Therapeutics Financials at a Glance

Market Cap

$162.15M

Revenue (TTM)

$0.00

Net Income (TTM)

$26.97M

EPS (TTM)

$-3.35

P/E Ratio

-12.30

Dividend

$0.00

Beta (Volatility)

0.86 (Low)

Price

$40.92

Volume

1,679

Open

$39.54

Previous Close

$40.92

Daily Range

$39.54 - $42.75

52-Week Range

$14.00 - $44.00

VTVT News

No articles available.

VTVT: Motley Fool Moneyball Superscore

34

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About vTv Therapeutics

Industry

Biotechnology

Employees

26

CEO

Paul Jai Sekhri

Headquarters

High Point, NC 27265, US

VTVT Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-70%

Return on Capital

-39%

Return on Assets

-30%

Earnings Yield

-8.13%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$162.15M

Shares Outstanding

3.94M

Volume

1.68K

Short Interest

0.00%

Avg. Volume

41.31K

Financials (TTM)

Gross Profit

$16.00K

Operating Income

$32.81M

EBITDA

$32.79M

Operating Cash Flow

$25.25M

Capital Expenditure

$0.00

Free Cash Flow

$25.25M

Cash & ST Invst.

$88.93M

Total Debt

$0.00

vTv Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$2.00K

+60.0%

Gross Margin

0.00%

N/A

Market Cap

$162.15M

N/A

Market Cap/Employee

$7.05M

N/A

Employees

23

N/A

Net Income

$7.14M

-96.4%

EBITDA

$8.24M

-86.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$88.93M

+143.1%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-30.00%

N/A

Return on Invested Capital

-39.41%

N/A

Free Cash Flow

$9.25M

-91.7%

Operating Cash Flow

$9.25M

-91.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FBIOFortress Biotech, Inc.
$2.60+5.26%
GANXGain Therapeutics, Inc.
$1.85-4.64%
INKTMiNK Therapeutics, Inc.
$10.69+1.14%
HOWLWerewolf Therapeutics, Inc.
$1.01+5.38%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%
NOKNokia
$8.82+0.07%

Questions About VTVT

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.